WO1992000371A1 - Rosiers et leurs procedes de production et de transformation genetique - Google Patents
Rosiers et leurs procedes de production et de transformation genetique Download PDFInfo
- Publication number
- WO1992000371A1 WO1992000371A1 PCT/US1991/004412 US9104412W WO9200371A1 WO 1992000371 A1 WO1992000371 A1 WO 1992000371A1 US 9104412 W US9104412 W US 9104412W WO 9200371 A1 WO9200371 A1 WO 9200371A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medium
- callus
- cells
- auxin
- cytokinin
- Prior art date
Links
- 241000220317 Rosa Species 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims description 96
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 230000009466 transformation Effects 0.000 title description 28
- 230000002068 genetic effect Effects 0.000 title description 2
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 186
- 210000004027 cell Anatomy 0.000 claims abstract description 118
- 210000002257 embryonic structure Anatomy 0.000 claims abstract description 101
- 230000000392 somatic effect Effects 0.000 claims abstract description 92
- 210000001519 tissue Anatomy 0.000 claims abstract description 79
- 230000006698 induction Effects 0.000 claims abstract description 64
- 238000011069 regeneration method Methods 0.000 claims abstract description 57
- 230000008929 regeneration Effects 0.000 claims abstract description 56
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 48
- 241000589158 Agrobacterium Species 0.000 claims abstract description 38
- 238000012258 culturing Methods 0.000 claims abstract description 38
- 108091029865 Exogenous DNA Proteins 0.000 claims abstract description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 14
- 210000000349 chromosome Anatomy 0.000 claims abstract description 5
- 239000002609 medium Substances 0.000 claims description 219
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 96
- 229930192334 Auxin Natural products 0.000 claims description 78
- 239000002363 auxin Substances 0.000 claims description 78
- 239000004062 cytokinin Substances 0.000 claims description 78
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims description 77
- 210000001161 mammalian embryo Anatomy 0.000 claims description 57
- 241000196324 Embryophyta Species 0.000 claims description 54
- JLIDBLDQVAYHNE-YKALOCIXSA-N abscisic acid group Chemical group C\C(\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C)=C\C(O)=O JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 claims description 46
- 235000015097 nutrients Nutrition 0.000 claims description 40
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims description 26
- 239000003630 growth substance Substances 0.000 claims description 25
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 claims description 24
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 claims description 24
- 229940023877 zeatin Drugs 0.000 claims description 24
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 claims description 23
- 238000012423 maintenance Methods 0.000 claims description 22
- 230000000408 embryogenic effect Effects 0.000 claims description 21
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims description 20
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims description 20
- 229960001669 kinetin Drugs 0.000 claims description 20
- 230000035800 maturation Effects 0.000 claims description 18
- 239000002689 soil Substances 0.000 claims description 18
- 238000012546 transfer Methods 0.000 claims description 16
- 239000012869 germination medium Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000003550 marker Substances 0.000 claims description 13
- 230000001939 inductive effect Effects 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 11
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000011161 development Methods 0.000 claims description 10
- 230000018109 developmental process Effects 0.000 claims description 10
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 238000004114 suspension culture Methods 0.000 claims description 8
- 239000005595 Picloram Substances 0.000 claims description 7
- 230000004069 differentiation Effects 0.000 claims description 7
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000012877 elongation medium Substances 0.000 claims description 6
- 230000001018 virulence Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 239000006870 ms-medium Substances 0.000 claims description 3
- 230000001902 propagating effect Effects 0.000 claims description 3
- 230000005087 leaf formation Effects 0.000 claims description 2
- JLJLRLWOEMWYQK-GDUNQVSHSA-N giberellic acid Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)C1C(O)=O)CC2[C@@]2(OC3=O)C1[C@]3(C)[C@@H](O)CC2 JLJLRLWOEMWYQK-GDUNQVSHSA-N 0.000 claims 3
- 229930002203 giberellic acid Natural products 0.000 claims 3
- 230000010261 cell growth Effects 0.000 claims 1
- 239000012882 rooting medium Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 12
- 238000011534 incubation Methods 0.000 abstract description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 24
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 22
- 229930006000 Sucrose Natural products 0.000 description 20
- 239000005720 sucrose Substances 0.000 description 20
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 19
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 19
- 229930027917 kanamycin Natural products 0.000 description 17
- 229960000318 kanamycin Drugs 0.000 description 17
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 17
- 229930182823 kanamycin A Natural products 0.000 description 17
- 244000154511 Rosa hybrid cultivar Species 0.000 description 15
- 235000002315 Rosa hybrid cultivar Nutrition 0.000 description 15
- 229960003495 thiamine Drugs 0.000 description 15
- 229940088594 vitamin Drugs 0.000 description 15
- 229930003231 vitamin Natural products 0.000 description 15
- 235000013343 vitamin Nutrition 0.000 description 15
- 239000011782 vitamin Substances 0.000 description 15
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 14
- 238000003556 assay Methods 0.000 description 13
- 239000006285 cell suspension Substances 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- 239000003617 indole-3-acetic acid Substances 0.000 description 12
- 235000008160 pyridoxine Nutrition 0.000 description 12
- 239000011677 pyridoxine Substances 0.000 description 12
- 229940011671 vitamin b6 Drugs 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- 239000005980 Gibberellic acid Substances 0.000 description 11
- 239000004471 Glycine Substances 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 11
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 11
- 229960003512 nicotinic acid Drugs 0.000 description 11
- 235000001968 nicotinic acid Nutrition 0.000 description 11
- 239000011664 nicotinic acid Substances 0.000 description 11
- 230000035784 germination Effects 0.000 description 10
- 108060001084 Luciferase Proteins 0.000 description 9
- 239000005089 Luciferase Substances 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 9
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 108700008625 Reporter Genes Proteins 0.000 description 7
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 7
- 229960003669 carbenicillin Drugs 0.000 description 7
- 235000019157 thiamine Nutrition 0.000 description 7
- 239000011721 thiamine Substances 0.000 description 7
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 7
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 229960000367 inositol Drugs 0.000 description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 6
- 239000011747 thiamine hydrochloride Substances 0.000 description 6
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 241001575049 Sonia Species 0.000 description 5
- 238000009630 liquid culture Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000002363 herbicidal effect Effects 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 229940064880 inositol 100 mg Drugs 0.000 description 4
- 238000004161 plant tissue culture Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000020415 coconut juice Nutrition 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- -1 morphology Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 239000012137 tryptone Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- 244000181025 Rosa gallica Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 230000030118 somatic embryogenesis Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- PQYUTHWOFMQAJO-SDBHATRESA-N (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-2-(3-methylbutyl)oxolane-3,4-diol Chemical compound C1=NC2=C(N)N=CN=C2N1[C@]1(CCC(C)C)O[C@H](CO)[C@@H](O)[C@H]1O PQYUTHWOFMQAJO-SDBHATRESA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- 239000005972 6-Benzyladenine Substances 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 101001040924 Arabidopsis thaliana Auxin-responsive protein IAA3 Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 235000010295 Rosa x kordesii Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 231100000071 abnormal chromosome number Toxicity 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- BIGPRXCJEDHCLP-UHFFFAOYSA-N ammonium bisulfate Chemical compound [NH4+].OS([O-])(=O)=O BIGPRXCJEDHCLP-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000002837 defoliant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 108010060641 flavanone synthetase Proteins 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000017363 positive regulation of growth Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Definitions
- the present invention relates generally to plant tissue culture methods and to methods for genetically altering the cells of higher plants. More particularly, the invention relates to methods for producing somatic embryos of Rosa hybrida , and obtaining regenerated plants therefrom and to methods for genetically transforming cells from rose plants.
- the hybrid tea rose, .Rosa hybrida is one of the most popular of all cultivated plants. As with any valuable plant species, breeders have long been working to improve existing varieties and create new varieties using conventional cross-breeding techniques. Characteristics of particular interest include color, fragrance, morphology, herbicide resistance, pesticide resistance, environmental tolerance, vase life of the cut flower, and the like. While improvements and variations in most or all of these areas have been achieved, progress is slow because of the perennial nature of the plant and the high incidence of plant sterility caused by abnormal chromosome numbers.
- Tissue culture often provides a natural source of variation, as well as a convenient medium in which mutagenesis can be carried out.
- in vitro transformation can be used as a tool for plant improvement, provided regeneration of the transformed plants can be achieved.
- Recombinant DNA technology can also be used to produce new rose cultivars in a controlled and predictable manner. It would be particularly desirable to be able to genetically transform individual rose plant cells to introduce a desired characteristic and to be able to regenerate viable somatic embryos and rose plantlets from the modified cells. Such methods should be capable of introducing preselected exogenous genes to the rose plant cell and should permit selection of transformed cells which are capable of expressing the gene. The method should produce regenerated rose plants which have stably incorporated the gene(s) .
- the present invention is directed to a method for controlled regeneration of a rose plant, particularly a i?ose hybrida plantlet, from a somatic embryo which comprises:
- the invention is further directed to a method for obtaining at least one somatic embryo from mature somatic tissue of Rose hybrida which comprises:
- somatic embryos comprising effective amounts of a nutrient medium, an energy source, an auxin and a cytokinin to obtain at least one somatic embryo.
- the mature somatic tissue may for example be obtained from a stamen filament, a leaf explant or a cell suspension culture.
- the ratio of auxin to cytokinin in the regeneration medium may be decreased by a factor of at least two to about 15 relative to the ratio of auxin to cytokinin present in callus induction medium and/or the source of the auxin and cytokinin in the regeneration differs from the source of the auxin and cytokinin in the callus induction medium.
- the ratio of auxin to cytokinin in the regeneration medium may be two to fifteen fold less than the ratio of auxin to cytokinin in the induction medium if the somatic tissue is obtained from a stamen filament or cell suspension culture.
- the ratio of auxin to cytokinin may be increased relative to the ratio of auxin to cytokinin present in callus induction medium and/or the source of the auxin and cytokinin in the regeneration differs from the source of the auxin and cytokinin in the callus induction medium.
- somatic embryos and the developmental capacity of such embryos provides convenient raw material for carrying out current methods of plant transformation, such as ballistic methods of DNA recovery, or Agrobacterium culture.
- the present invention further comprises methods for genetically transforming rose plant embryonic tissue or callus cells and, in the preferred embodiments, for regenerating the transformed tissue or callus cells into somatic embryos and ultimately back into viable rose plantlets.
- the tissue or callus cells are transformed by incubation with Agrobacterium cells carrying an exogenous DNA sequence which typically includes a selectable marker gene as well as one or more genes to be expressed.
- Transformed tissue or callus cells are selected, typically on a medium which inhibits growth in the absence of the marker, and may be regenerated into somatic embryos and plantlets which stably incorporate the DNA sequence(s) .
- the present invention further comprises rose callus cells, somatic rose embryos, and rose plantlets which incorporate exogenous DNA sequences.
- such transformed cells, embryos, and plantlets are obtained by the methods of the present invention.
- the methods of the present invention provide a particularly convenient technique for selectively breeding new rose cultivars in a predictable and expeditious manner. It is expected that a variety of traits, such as color, fragrance, morphology, herbicide resistance, pesticide resistance, flower vase life, environmental tolerance, and other horticultural traits, may be intentionally introduced into the callus cells and stably incorporated into the chromosomes of the regenerated embryos and plantlets.
- Figure 1 shows various stages of somatic embryogenesis from filament explants of Rosa hybrida var. Royalty.
- A Early stage of differentiation from primary callus (right) and globular embryos (left); bar 2.0 mm;
- Figure 2 shows various stages of somatic embryogenesis from leaf explants of Rosa hybrida var. Sonia.
- A Shoots from axillary buds after 3 weeks in culture; bar 14.3 mm;
- B Spongy callus formed from leaf after 4 weeks on primary medium; bar 1.1 mm;
- C Early stages of embryo differentiation from primary callus after 6 weeks on regeneration medium; bar 1.2 mm;
- D Globular embryo differentiation from semi-friable embryogenic tissue; bar 1.2 mm;
- E Globular embryo proliferation; bar 1.2 mm;
- F Enlargement of globular embryo proliferation; bar 0.5 mm.
- Figure 3 shows various stages of an embryogenic cell suspension from mature leaf callus of Rosa hybrida var . Royalty.
- A Primary callus growth from mature leaf explant after 3 weeks in culture; bar 6.2 mm;
- B Compact white embryogenic tissue derived from oxidized globular callus in liquid culture; bar 1.1 mm;
- C Fine cell suspension from compact embryogenic tissue; bar 10.0 mm;
- D Regeneration of rose somatic embryos from cell suspension after 4 weeks on solid medium; bar 0.7 mm.
- Figure 4 shows the general procedure used to generate plantlets from stamen filaments from .Rosa hybrida var. Royalty.
- Figure 5 shows the general procedure used to generate somatic embryos from leaf explants from Rosa hybrida var. Sonia.
- Figure 6 shows the general procedure used to generate somatic embryos from cell suspensions from Rosa hybrida var. Royalty.
- Figure 7 is a map of binary plasmid pJJ3499 used in Example 1 in the Experimental section hereinafter.
- FIG. 8 illustrates the T-DNA region of plasmid pJJ3491 used in Example 2 of the Experimental section hereinafter.
- Plasmid pJJ3931 carries a nos/NPT fusion and a 35S/luciferase fusion.
- Figure 9 is a bar graph luminescence measurements from transformed rose embryogenic calli bearing the firefly luciferase gene. Fifteen putative transformed calli (no. 1-15) and 12 non-transformed control calli (designated by C) were placed individually in 60 ⁇ l of 200 ⁇ M luciferin solution in 1.5 ml microcentrifuge tubes for 30 minutes in the dark. The tubes then were placed in scintillation vials and measured in a scintillation counter (Packard Instrument Co., Downers, Grove, IL, USA). The bars represent the number of light units emitted from each sample in terms of log scale of cp (counter per minute) . The assay was performed generally as described in Ow et al. (1986) Science 234:856-859.
- This invention is directed to methods producing at least one somatic embryo of .Rosa hybrida, and obtaining at least one regenerated plant therefrom.
- Four steps are involved in obtaining mature plantlets using the method of the present invention: (a) production of a somatic embryo; (b) culturing the somatic embryo on a maturation medium capable of inducing differentiation of the embryo; (c) germinating the differentiated embryo on germination medium; and (d) propagating the germinated embryo on propagation medium to produce a mature plantlet capable of being transferred to soil conditions.
- the present invention is also directed at obtaining genetically transformed rose plants, cells, and embryos by the selective introduction of exogenous DNA sequence(s) into the chromosomes of cultured rose callus cells.
- the methods require certain starting materials, including rose callus cells, the DNA sequence(s) to be introduced, Agrobacterium cells to carry the DNA sequence(s) and mediate their transfer to the rose callus cells, and culture media suitable for the steps of callus induction, DNA transfer, and embryo and plantlet regeneration, as described in much greater detail hereinbelow. Each of the necessary starting materials will now be described.
- Somatic embryo Structures similar to zygotic embryos which arise from somatic cells.
- the plants derived from the rose somatic embryos are distinguished from previous tissue culture-produced rose plants in that the plants are not obtained simply by stimulation of growth of preformed meristematic tissue.
- Embryonic Capable of becoming somatic embryos.
- rose calli have surface structures (e.g., about 0.5 mm to l mm) which are capable of becoming embryos.
- Pre-embryogenic Capable of becoming embryogenic. In rose, these calli are friable, whitish-creamish, granular.
- Undifferentiated cell mass produced usually by culture of different organs in vitro. It can be hard, soft, dispersible, compact, spongy, dry, watery, or etc.
- Somatic Cell Any of the body of an organism except the germ cells (sexual reproductive cells) .
- Nutrient Media Media that comprises salts, a carbon source and vitamins at concentrations necessary to effect the maintenance of cultured plant cells.
- Rose plant tissue which is used for producing callus cells may be obtained from any species of the rose genus, Rosa. Exemplary species include Rosa damascena, Rosa multiflora, Rosa gallica, Rosa hybrida, and the like. Of particular interest are various cultivars of Rosa hybrida , such as Royalty, Frisco, Sonia, and the like.
- the plant tissue used for the production of callus cells may be mature or immature, preferably being mature somatic tissue.
- Suitable immature plant tissue can be obtained from in vitro plant tissue culture techniques, such as those described in Ammirato et al. (eds) , Handbook of Plant Cell Culture , vol. 5, McGraw- Hill Publishing Co., New York, 1990, particularly at Chapter 29, pages 716-747, the disclosure of which is incorporated herein by reference.
- Callus cells obtained from tissue culture materials may be subjected to a "cell suspension" step prior to transformation as described below.
- Such cell suspension comprises suspending the cells in a liquid culture medium and shaking the suspension, typically at about 100 to 500 rpm. In some cases, cell suspension may be useful to the production of embryonic cells.
- the preferred mature somatic plant tissues may be obtained from any part of the mature rose plant that is capable of producing calli. Suitable plant parts include stamen filaments, leaf explants, stem sections, shoot tips, petal, sepal, petiole, peduncle, and the like, with stamen filaments and leaf explants being particularly preferred.
- the mature plant tissue sources will be disinfected prior to introduction to the callus induction culture.
- a suitable disinfection step comprises an alcohol wash, e.g., with 75% ethanol for about one minute, followed by a wash with bleach (10%) and a suitable detergent, e.g., 0.1% Tween®, for 20 minutes.
- the plant materials are then rinsed, usually two to three times for about five minutes each time, with sterile, deionized water prior to culturing.
- Suitable stamen filaments will have a length from about 0.5 to 1.5 cm, preferably being about 1 cm.
- the stem and leaf sections are preferably cut to a size below about 1 cm x 1 cm, preferably being about 0.5 cm x 0.5 cm.
- the exogenous DNA sequences to be introduced will usually carry at least one selectable marker gene to permit screening and selection of transformed callus cells (i.e., those cells which have incorporated the exogenous DNA into their chromosomes) , as well as one or more "functional" genes which are chosen to provide, enhance, suppress, or otherwise modify expression of a desired trait or phenotype in the resulting plant.
- selectable marker gene i.e., those cells which have incorporated the exogenous DNA into their chromosomes
- Such traits include color, fragrance, herbicide resistance, pesticide resistance, disease resistance, environmental tolerance, morphology, growth characteristics, and the like.
- the functional gene to be introduced may be a structural gene which encodes a polypeptide which imparts the desired phenotype.
- the functional gene may be a regulatory gene which might play a role in transcriptional and/or translational control to suppress, enhance, or otherwise modify the transcription and/or expression of an endogenous gene within the rose plant. It will be appreciated that control of gene expression can have a direct impact on the observable plant characteristics.
- Other functional "genes" include sense and anti-sense DNA sequences which may be prepared to suppress or otherwise modify the expression of endogenous genes. The use of anti-sense is described generally in van der Krol et al., (1990) Mol. Gen. Genet. 220:204-212, the disclosure of which is incorporated herein by reference.
- Structural and regulatory genes to be inserted may be obtained from depositories, such as the American Type Culture Collection, Rockville, Maryland 20852, as well as by isolation from other organisms, typically by the screening of genomic or cDNA libraries using conventional hybridization techniques, such as those described in Maniatis et al.. Molecular Cloning - A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1985) .
- Screening may be performed by (1) nucleic acid hybridization using homologous genes from other organisms, (2) probes synthetically produced to hybridize to particular sequences coding for desired protein sequences, or (3) DNA sequencing and comparison to known sequences. Sequences for specific genes may be found in various computer databases, including GenBank, National Institutes of Health, as well as the database maintained by the United States Patent Office.
- Transposon tagging can also be used to aid the isolation of a desired gene.
- Transposon tagging typically involves mutation of the target gene. A mutant gene is isolated in which a transposon has inserted into the target gene and altered the resulting phenotype. Using a probe for the transposon, the mutated gene can be isolated. Then, using the DNA adjacent to the transposon in the isolated, mutated gene as a probe, the normal wild-type allele of the target gene can be isolated.
- the selectable marker gene on the DNA sequences to be inserted will usually encode a function which permits the survival of transformed callus cells in a selective medium.
- the selectable marker gene will encode antibiotic resistance, particularly kanamycin resistance, hygromycin resistance, streptomycin resistance, chlorosulfuron resistance, (herbicide resistance) , or the like.
- the composition of a suitable selective medium is described hereinbelow.
- the DNA sequences may also contain a reporter gene which facilitates screening of the transformed callus cells and plant material for the presence and expression of the exogenous DNA sequences.
- Exemplary reporter genes include /S-glucuronidase and luciferase, as described in more detail hereinafter.
- the exogenous DNA sequences will be introduced to the callus cells by incubation with Agrobacterium cells which carry the sequences to be transferred within a transfer DNA (T-DNA) region found on a suitable plasmid, typically the Ti plasmid.
- T-DNA transfer DNA
- Ti plasmids contain two regions essential for the transformation of plant cells. One of these, the T-DNA region, is transferred to the plant nuclei and induces tumor formation.
- the other, referred to as the virulence (vir) region is essential for the transfer of the T-DNA but is not itself transferred.
- the Ti plasmid will be modified to delete or inactivate the tumor-causing genes so that they are suitable for use as vector for the transfer of the gene constructs of the present invention.
- Other plasmids may be utilized in conjunction with Agrobacterium for transferring the DNA sequences of the present invention to callus cells.
- the construction of recombinant Ti plasmids may be accomplished using conventional recombinant DNA techniques, such as those described in Maniatis et al. , supra .
- the plasmids will include additional selective marker genes which permit manipulation and construction of the plasmid in suitable hosts, typically bacterial hosts other than Agrobacterium, such as E. coli .
- Suitable selective marker genes include tetracycline resistance, kanamycin resistance, ampillcilin resistance, and the like.
- the genes within the DNA sequences will typically be linked to appropriate transcriptional and translational control sequences which are suitable for the rose plant host.
- the gene will typically be situated at a distance from a promoter corresponding to the distance at which the promoter is normally effective in order to ensure transcriptional activity.
- a polyadenylation site and transcription termination sites will be provided at the 3'-end of the gene coding sequence.
- the necessary control functions can be obtained together with the structural gene when it is isolated from a target plant of other host.
- Such intact genes will usually include coding sequences, intron(s) , a promoter, enhancers, and all other regulatory elements either upstream (5 1 ) or downstream (3') of the coding sequences.
- a binary vector system may be used to introduce the DNA sequences according to the present invention.
- a first plasmid vector strain would carry the T-DNA sequence while a second plasmid vector would carry a virulence (vir) region.
- vir virulence
- Suitable Agrobacterium strains include Agrobacterium tumefaciens and Agrobacterium rhizogenes . While the wild-type Agrobacterium rhizogenes may be used, the Agrobacterium tumefaciens should be "disarmed,” i.e., have its tumor-inducing activity removed, prior to use.
- Preferred Agrobacterium tumefaciens strains include LBA4404, as described by Hoekema et al. (1983) Nature, 303:179-180, and EHA101 (Hood et al. (1986) J.
- a preferred Agrobacterium rhizogenes strain is 15834, as described by Birot et al. (1987) Plant Physiol. Biochem. , 25:323-325.
- the Agrobacterium strain(s) carrying the desired exogenous DNA sequence(s) will usually be cultured for a period of time prior to incubation with the rose callus cells.
- the Agrobacterium may be cultured on a solid media including nutrients, an energy source, and a gelling agent. Suitable nutrients include salts, tryptone, and yeast extracts, while most sugars are suitable as the energy source and the gelling agent can be agar. Gel-rite®, or the like.
- a preferred medium is L-Broth, which is described in detail in the Experimental section hereinafter.
- medium will include an antibiotic to select for Agrobacterium carrying the plasmid DNA sequences.
- the Agrobacterium cells are typically cultured for about one to three days, preferably in the dark at about 28°C, and are collected while still a white- creamish color, i.e., before browning, typically by being scraped off the solid medium.
- the cells are then suspended in a liquid medium, e.g., L-broth, or more preferably in an induction broth containing the following components: Broad Range Preferred
- the Agrobacterium cells are cultured in the L-broth or induction broth for about one to ten hours, preferably from about two to three hours, while being agitated, preferably at moderate temperatures from about 20°C to 30°C.
- Somatic embryo production may be achieved as follows. Two steps are involved in the production of a somatic embryo(s) from mature somatic tissue of J?osa hybrida : (a) culturing mature somatic tissue on callus induction medium comprising effective amounts of a nutrient medium, an energy source, an auxin, and a cytokinin to obtain at least one induced callus; and (b) culturing the induced callus or calli in a regeneration media capable of inducing completion of the development of somatic embryos comprising effective amounts of a nutrient medium, an energy source, an auxin, and a cytokinin to obtain somatic embryos.
- a step which comprises the culturing of the induced callus or calli on maintenance media to isolate the induced callus or calli and increase the quantity of induced calli before the induced calli may be regenerated to produce somatic embryos.
- Callus induction may be achieved as follows. Rose tissue is obtained from any of the plant parts described above and placed in a callus induction medium including suitable nutrients, an energy source, growth regulators, and the like, selected to induce callus formation in the plant material.
- a variety of basal nutrient media are known which provide adequate supplies of nitrogen and salts to support callus growth, such as White's, B5, N6 and MS medium.
- Any sugar may be employed as energy source. Among the appropriate choices are glucose, maltose, sucrose, or lactose, or sucrose in combination with any of the named sugars, or mannose.
- a preferred sugar for this purpose is sucrose, at a level of about 10-50 g/1, but molar equivalents of other sugars may also be employed.
- Callus induction medium preferably contains at least one auxin and at least one cytokinin.
- the auxins may be any auxin, natural or synthetic, for example, indole acetic acid (IAA) , naphthalene acetic acid (NAA) , 2,4-dichlorophenoxy acetic acid (2,4-D), picloram, and dicamba.
- the cytokinin may be selected from any of the known cytokinins, natural or synthetic, for example 6- benzyladenine (6-BA) , zeatin (ZEA) , kinetin (KIN) , and isopentyladenosine (iP) . Callus may be induced in the presence of several combinations of auxin and cytokinin.
- an induction medium comprising 2,4-D and zeatin.
- An alternate useful combination is NAA with kinetin.
- an auxin will be present in an amount of about 0.1 to 10 mg/ml, and cytokinin in an amount of about 0.2 to 15.0 mg/ml.
- the concentration in the medium is preferably from about 0.5 to 2.5 mg/1, and most preferably about 2.0 mg/1.
- the amount is preferably from about 0.5 to 10.0 mg/1 and most preferably about 2.5 mg/1.
- the concentration in the medium is preferably from about 0.5 to 5 mg/1 and most preferably about
- zeatin When zeatin is used, the concentration is preferably from about 0.2 to 12.5 mg/1 and most preferably about 1.5 mg/1.
- Other nonessential components may also be added to the medium to optimize callus induction.
- amino acids such as glycine, may be employed as a nitrogen source.
- additional growth regulators may be helpful in promoting callus induction.
- ABA abscisic acid
- addition of abscisic acid (ABA) in the amount of about 0.1 to 0.2 mg/1 may be useful in callus induction, particularly to promote a more globular callus, which leads to embryogenic tissue.
- ABA may be used with all explant sources, but has been especially useful with the culture of in vitro leaf explants.
- a maintenance medium Prior to transfer of callus to regeneration medium, it may be desirable (usually in the case of transformation) to transfer the callus to a maintenance medium.
- This medium is used to isolate friable embryogenic tissue or callus, and to favor this type of callus prior to regeneration. Although regeneration can occur without a maturation phase, the transfer of callus to a maintenance medium permits better control and proliferation of a particular callus cell line.
- the primary components of a maintenance medium are, an appropriate basic medium with inorganic nutrients, at least one growth regulator, and energy sources. Any sugar may be used as an energy source.
- the growth regulator may be selected from the group including but not limited to an auxin, a cytokinin, abscisic acid, and gibberellic acid.
- the auxins may be any auxin, natural or synthetic, for example, IAA, NAA, 2,4-D, and picloram.
- An auxin will be present in an amount of about 0.1-10 mg/ml.
- Cytokinin may be selected from any of the known-cytokinin, natural or synthetic, for example, 6-BA, ZEA, KIN, and iP.
- a cytokinin may be present in an amount of about 0.2-15.0 mg/ml.
- Abscisic acid may be present in the amount of,about 0.2-2 mg/1.
- Gibberellic acid may be present in the amount of about 0.5-5 mg/1.
- Callus maintenance is continued for as long as practically possible, preferably with periodic subculturing. Generally, pre-embryogenic callus can be maintained for about 12-24 months or longer.
- the cells after induction may be transferred to a specific maintenance medium, SM-1, which promotes cell proliferation without oxidation of tissue explants in culture.
- SM-1 a specific maintenance medium
- the utility of the SM-1 medium lies in the presence of ABA and 2,4-D.
- 2,4-D is present at a concentration of about 1.65 mg/1 and ABA is present at a concentration of about 0.26 mg/1.
- one or more conditioning media may be used prior to transfer to maintenance media to enable the selection of a friable cell line in liquid culture.
- the conditioning media comprises an appropriate basic medium with inorganic nutrients, a growth regulator, and an energy source. Any sugar may be used as any energy source.
- the growth regulator may be selected from the group including but not limited to an auxin, a cytokinin, abscisic acid, and gibberellic acid.
- the auxins may be any auxin, natural or synthetic, for example, IAA, NAA, 2,4-D, and picloram.
- Cytokinin may be selected from any of the known cytokinin, natural or synthetic, for example, 6-BA, ZEA, KIN, and iP.
- a cytokinin may be present in an amount of about 0.2-15.0 mg/1.
- Abscisic acid may be present in the amount of about 0.2-2 mg/1.
- Gibberellic acid may be present in the amount of about 0.5-5 mg/1.
- the callus may be cultured in the conditioning media for about 3-6 weeks.
- the rose callus cells may be transformed according to the method of the present invention.
- the rose tissue is first cultured on the callus induction medium for a time sufficient to produce at least one callus which serves as a source of dispersed callus cells for transformation.
- tissue may be maintained in the callus induction medium for from about three to thirteen weeks, usually from about seven to ten weeks, and preferably for about eight weeks, to yield a fast growing callus.
- callus morphology may be hard, spongy, watery, sandy, or globular, and may have a white, cream, or yellow color, depending on the particular composition of the medium.
- the preferred morphology for use in the transformation methods of the present invention occurs after from about seven to ten weeks, usually at about eight weeks, when the calli become highly friable or dispersable with a whitish- creamish color and a granular consistency. While cells from calli having these characteristics have been found to be most suitable, cells from calli which are hard and compact may also be used for transformation by cutting into small sections, typically having dimensions of about 2 to 3 mm.
- Calli cultured as just described may be used directly as the source of callus cells for transformation or may be subcultured prior to use as a starting material. Subculturing allows the continuing maintenance of callus cells as a source of starting materials for the method of the present invention.
- the callus material described above is incubated with the Agrobacterium cells carrying the exogenous DNA sequence to be transferred, typically for about one to four days. Incubation is achieved in a cocultivation medium which includes nutrients, an energy source, and an induction compound which is selected to induce the virulence (vir) region of Agrobacterium to enhance transformation efficiency.
- the induction compound can be any phenolic compound which is known to induce such virulence, preferably being acetosyringone (AS) present at from about 10 to 200 ⁇ M, preferably at about 100 ⁇ M. Suitable phenolic compounds are described in Bolton et al. (1986) Science 232:983-985.
- the preferred cocultivation medium includes sucrose (20 g/1) as the energy source, 2,4-D (5 mg/1) as the auxin, and zeatin (1 mg/1) as the cytokinin. Gibberellic acid (1 mg/1) is also preferably present as a growth regulator.
- a preferred formulation for the cocultivation medium is N12AS set forth in the Experimental section hereinafter.
- Callus cells are combined with the Agrobacterium cells in the cocultivation medium at a moderate temperature, typically in the range from about 20 to 28°C, preferably at about 24 ⁇ C, from about one to four days, usually from about one to two days.
- the medium is preferably kept in the dark, and the cocultivation continued until the Agrobacterium have grown sufficiently so that colonies are observable on the calli, either directly or through a microscope.
- the Agrobacterium cells are present at a concentration from about 10 7 to 10 10 cells/ml, preferably at about 10 9 cells/ml.
- the callus cells are present at a ratio of from about 1:1 to about 10:1 (callus cells : Agrobacterium cells), preferably at about 3:1, on a volume basis.
- a total of about 1 to 100 ml of callus material is used, preferably about 10 ml, in a total culture volume of about 1 to 100 ml, preferably about 10 to 12 ml.
- the callus cells and Agrobacterium cells are placed on a filter paper matrix, such as Whatman #1, on the cocultivation medium.
- the callus cells are washed from the Agrobacterium cells with water or a culture medium containing nutrients, an energy source, growth regulators, and the like.
- a culture medium typically containing nutrients, an energy source, growth regulators, and the like.
- the transformed calli are mixed with the wash medium, typically at a volume ratio of from about 1:3 to about 1:30 (calli:liquid) , preferably at about 1:10, and centrifuged, preferably at 500 rpm for about 5 minutes.
- the resulting liquid fraction containing most of the bacteria is removed, while the denser fraction containing the calli is saved.
- the wash is repeated, typically from two to six times, with antibiotics being used in at least the later washes in order to kill any remaining Agrobacterium cells.
- Any antibiotic capable of killing Agrobacterium may be used, with carbenicillin (200 to 1000 mg/1) , vancomycin (100 to 500 mg/1) , cloxacillin (200 to 1000 mg/1) cefotaxin (200 to 1000 mg/1) , and erythromycin (200 to 1000 mg/1) , being preferred.
- the calli are placed on a suitable selection medium including a plant selection agent which permits identification of transformed calli based on the presence of the marker introduced as part of the exogenous DNA.
- the selective media is placed in a petri dish with portions of the calli, typically about 100 mg each.
- the selection medium is a general growth medium, such as N12 or M53 (as described in the Experimental section hereinafter) supplemented with the plant selection agent, and usually including the anti-Agrro.bacterium antibiotic.
- Suitable plant selection agents include the following.
- Preferred selection media are N12 and M53 (see Experimental section hereinafter) containing no cytokinin or auxins, but having abscisic acid added at from about 0.5 to 4 mg/1, preferably at about 2 mg/1. M53 is particularly preferred when the callus structures are sized from about 0.4 to 0.7 mm. When kanamycin resistance is the selectable marker, N12CK and M53CK (see Experimental section hereinafter) are particularly suitable.
- the selection culture will be maintained for a time sufficient to permit transformed callus cells to grow and produce white-cream colored calli, while the non-transformed callus cells turn brown and die.
- the selection culture will last from about 25 to 50 days, depending primarily on the concentration of the plant selective agent. For example, thirty days is generally sufficient for kanamycin at 300 mg/1, while fifty days is suitable for kanamycin at 200 mg/1.
- the primary criterion in ending the selection culture is a clear distinction between proliferating cells which have been transformed and non-proliferating cells which have not been transformed.
- reporter genes and assays include 3-glucurpnidase (GUS) assays as described by Jefferson, G ⁇ S Gene Fusion Systems User' s Manual , Cambridge, England (1987) and luciferase assays as described by Ow (1986) Science 234:856-859. It will be appreciated that these assays can be performed immediately following the transformation procedures or at any subsequent point during the regeneration of the transformed plant materials according to the present invention.
- a regeneration medium for generation of somatic embryos.
- This medium contains as its principle elements an auxin, a cytokinin, an energy source, and an appropriate nutrient medium such as White's or B5 media.
- the medium will also include an anti-Agrro acterium antibiotic and, usually, ABA or gibberellic acid.
- Preferred post-transformation regeneration media are M53C (particularly if N12CK was the selection medium) and M20C (particularly if M53CK was the selection medium) .
- the formulation of the regeneration medium may be adjusted depending on the source of somatic tissue.
- the ratio of auxin to cytokinin may be decreased by a factor of at least two and up to as much as 15 relative to the ratio of auxin to cytokinin present in callus induction medium and/or the source of the auxin and cytokinin in the regeneration will differ from the source of the auxin and cytokinin in the callus induction medium.
- a weaker cytokinin and auxin is used in the regeneration media than in the induction media and selection medium.
- 2,4-D is a stronger auxin, i.e., has a greater effect on growth regulation than NAA and zeatin is a stronger cytokinin than kinetin.
- regeneration of filaments can occur in a medium comprising 2,4-D/zeatin at a ratio of 1.3, compared with NAA/kinetin at a ratio of 4.0 in callus induction medium.
- the ratio of auxin to cytokinin may be increased relative to the ratio of auxin to cytokinin present in callus induction medium and/or the source of the auxin and cytokinin in the regeneration medium will differ from the source of the auxin and cytokinin in the callus induction medium.
- regeneration of leaf explants can occur in a maintenance medium comprising NAA/KIN at a ratio of 2.0 compared with 2,4- D/zeatin at a ratio of 1.3.
- Preferred regeneration media for use with transformed calli are M53C (particularly if N12CK was the selection medium) and M20C (particularly if M53CK was the selection medium) .
- the period on regeneration medium generally takes about 20 to 60 days, usually about 30 days.
- Globular to heart-shaped embryos will usually be apparent on the surface of the culture after this time. In many cases, the embryos so formed are capable, upon subculture, to give rise on their outer surface to secondary embryos. If this secondary embryo production is specifically desired, the globular embryos can be transferred to fresh regeneration media and cultured from 3 to 6 weeks.
- the somatic embryos produced as just described can be repeatedly subcultured in order to provide for an increased number of transformed embryos.
- somatic embryos are also useful targets for plant transformation via ballistic methods (Sanford, etc.).
- a maturation process Maturation of somatic embryos is accomplished by transfer of globular embryos to a medium comprising nutrients, an energy source, and a growth regulator which may include but is not limited to an auxin, a cytokinin, abscisic acid, and gibberellic acid.
- the auxins may be any auxin, natural or synthetic, for example, IAA, NAA, 2,4-D, and picloram.
- the auxin will be present in an amount of about 0.1 to 10 mg/ml.
- the cytokinin may be selected from any of the known cytokinins, natural or synthetic, for example, 6-BA, ZEA, KIN, and iP.
- a cytokinin may be present in an amount of about 0.2 to 15.0 mg/ml.
- Abscisic acid may be present in the amount of about 0.2 to 2 mg/1.
- Gibberellic acid may be present in the amount of about 0.5 to 5 mg/1.
- a preferred maturation medium is M20 (see Experimental section hereinafter) .
- Callus cells are held on the maturation medium with subculturing preferably about every 30 days, until mature somatic embryos are obtained.
- the period of maturation generally takes about three to six weeks.
- Globular embryos will appear on the surface of the maturation medium, with many embryos giving rise on their outer surface to secondary embryos. If such secondary embryo production is desired, the globular embryos can be transferred to fresh maintenance medium (as described above) and can be subcultured repeatedly in order to provide a greater number of embryos.
- Such subculturing is preferably performed on M20 medium.
- the mature somatic embryos produced as described above are next transferred to a germination medium in order to produce germinated embryos.
- the germination medium comprises nutrients and an energy source.
- the medium may further comprise a growth regulator which may include but is not limited to a cytokinin, abscisic acid, and gibberellic acid.
- the cytokinin may be present at a concentration of about 0.1 to 1.0 mg/1.
- Abscisic acid may be present in the amount of about 0.2 to 2 mg/1.
- Gibberellic acid may be present in the amount of about 0.5 to 5 mg/1.
- the germination media may also further comprise coconut water at about 5 to 15%, v/v.
- a preferred germination medium is M13.
- the somatic embryos are held on the germination medium for from about 1 to 45 days, usually about 24 days, to yield germinated embryos.
- embryo germination Early stages of embryo germination are characterized by hypocotyl elongation, cotyledonary leaves and chlorophyll development. In late stages of germination, cotyledonary leaves enlarge, the hypocotyl elongates, and a tap root develops. The differentiated embryos may be cultured on germination media for about 1 to 4 weeks. The result is somatic embryos with shoots 1 to 4 mm in length having from 2 to 4 leaves.
- the germinated embryos may be transferred to a shoot elongation medium to produce elongated shoots.
- the medium will include nutrients, an energy source, and growth regulators, generally as described above, but will have a reduced salt concentration (up to 50% lower) and a reduced growth regulator content, preferably BA at 1 to 6 mg/1 and IAA at 0.1 to 1 mg/1.
- a preferred shoot elongation medium is M13-8 (see Experimental section hereinafter) .
- the embryos are maintained in the elongation medium until the shoots are about 10 to 20 mm in length and develop three to five fully green and elongated leaves and stems, typically requiring three to four weeks.
- the germinated (and optionally shoot elongated) embryos are subsequently transferred to a propagation (or shoot multiplication) medium which comprises appropriate nutrients, an energy source, an auxin, and a cytokinin.
- the auxin may be any auxin, natural or synthetic, for example, IAA, NAA, 2,4-D and picloram.
- the auxin will be present in an amount of about 0.1 to 10 mg/1.
- the cytokinin may be selected from any of the known cytokinins, natural or synthetic, for example, 6-BA, ZEA, KIN, and iP.
- a cytokinin may be present in an amount of about 0.2 to 15.0 mg/1.
- the auxin is IAA, present at a concentration of about 0.3 mg/1 and the cytokinin is 6-BA, present at a concentration of about 3.0 mg/1.
- the nutrient media is selected from the group including but not limited to White's, MS, B5, and N6 media.
- a preferred propagation or shoot multiplication medium is M13 (see Experimental section hereinafter) .
- Any sugar may be employed as an energy source.
- the auxins may be any auxin, natural or synthetic, for example, IAA, NAA, 2,4-D, and picloram. An auxin will be present in an amount of about 0.1-10 mg/ml.
- Cytokinin may be selected from any of the known cytokinin, natural or synthetic, for example, 6-BA, ZEA, KIN, and iP. A cytokinin may be present in an amount of about 0.2-15.0 mg/ml.
- the germinated embryo may be cultured in propagation medium for about 20 to 200 days, preferably about 30 days.
- Well developed plantlets may be obtained and can be transferred to, for example, artificial soil for root regeneration.
- multiple shoots can be isolated from one single plantlet before transferring to soil.
- Root regeneration typically having a length in the range from about 10 to 40 mm and preferably having from about 5 to 10 leaves.
- the preferred method for root regeneration is to transfer the shoots to be rooted into small pots containing an artificial soil, typically saturated with a medium containing root inducing hormones.
- a suitable root induction contains nutrients but is deprived of sugar and other energy sources.
- the medium may further contain thiamine, preferably in the form of thiamine-HCl at about 0.5 to 2 mg/1, and an auxin, such as IAA at about 1 to 4 mg/1.
- a preferred root regeneration medium N3-4 (see Experimental section hereinafter) .
- the shoots While in the pots, the shoots may be placed in a container, such as a magenta GA-7 culture container and incubated in a growth chamber preferably under a regime of 16 hours light per 24 hour period.
- An alternate root regeneration method is to dip the shoots in a suitable root-inducing hormone, such as RooToneTM.
- a suitable root-inducing hormone such as RooToneTM.
- the shoots are then placed directly in the soil in the greenhouse, preferably being maintained under a plastic cover to maintain a high relative humidity.
- the cover can be gradually removed over a period of days in order to cause hardening of the shoots.
- roots are typically obtained in about 7 to 35 days.
- the rooted shoots can then be transplanted within the greenhouse or elsewhere in a conventional manner for tissue culture plantlets.
- Transformation of the resulting plantlets can be confirmed by assaying the plant material for any of the phenotypes which have been introduced by the exogenous DNA.
- suitable assays exist for determining the presence of certain reporter genes, such as ⁇ -glucuronidase and/or luciferase, as described hereinabove.
- Other procedures such as PCR, restriction enzyme digestion.
- Southern blot hybridization, and Northern blot hybridization may also be used. The methods described above, and in the following examples, have been applied to a number of different hybrid tea varieties, including "Sonia” and "Royalty".
- Kanamycin Kanamycin Sigma Chemical Co., St. Louis, Sulfate MO, USA
- TDZ Thidiazuron Purified from Dropp by dissolving in dimethylsulfoxide and passing through a 0.2 ⁇ m nylon filter.
- Nicotine acid 2.0 mg/1
- Nicotine Acid 0.5 mg/1
- N3-1 modified as follows:
- Stamen filaments of j_osa hybrida L. var. Royalty obtained from N.H. Wright, Inc., Nursery, Cranbury, NJ
- j_osa hybrida L. var. Royalty obtained from N.H. Wright, Inc., Nursery, Cranbury, NJ
- Buds were disinfected with clorox (10%)/Tween®-20 (0.1%) for 20 mins., rinsed three times with sterile deionized water and placed in callus induction medium (M130-3) . All media were autoclaved for 20 min. at 24°C and 15 psi after pH adjustment. Cultures in petri dishes were sealed with Parafilm and kept in the dark at 24°C. A fast-growing, semi-hard, yellow callus was obtained from filament explants after 3 weeks in M130-3. After subculture in this medium, the callus changed to a drier appearance. The callus was placed in maintenance medium
- M139 M139 medium improved callus quality preventing oxidation and leading to a less compact callus. 2. Pre-embryogenic callus induction medium and their maintenance.
- M139-2 pre- embryogenic friable callus induction (regeneration) medium
- Figure 1A Globular embryos were subcultured on the same medium and secondary embryos ( Figure IB) were formed on the outer surface of the primary embryos.
- the embryos matured 3 weeks after being transferred onto M9-21 and M9-2 ( Figures 1C-D) .
- the M9- 21 medium was based on N6 salts (Chu et al.
- M139-2 pre- embryogenic friable callus induction (regeneration) medium
- KM-8P vitamins Kao and Michayluk (1975) Planta, 126:105-110) and growth regulators were filter sterilized and added into the autoclaved portion of the proliferation medium.
- Agrobacterium rhizogenes wild-type strain 15834 (Birot et al. (1987) Plant Physiol. Biochem. 25:323-325) containing the binary vector pJJ3499 was used for transformation.
- pJJ3499 contains the nopaline synthase promoter and neomycin phosphotransferase II (NPT II) gene which confers kanamycin resistance as well as the cauliflower mosaic virus 35S promoter.
- NPT II neomycin phosphotransferase II
- the jS- glucuronidase gene (Jefferson (1986) Proc. Natl. Acad. Sci. USA 83:8447-8451) is present as a reporter gene.
- Strain 15834 alone was used as a control inoculum.
- Bacteria were maintained on L-broth medium solidified with 1.5% Bactoagar containing 10 mg/1 tetracycline. Bacteria were scraped off the solid medium using a loop and suspended in "Induction Broth" medium (Winans et al. (1989) J. Bact. 171:1616-1622) containing 100 ⁇ M acetosyringone, and cultured on a shaker (120 rpm) at 28°C for 3 hours.
- "Induction Broth" medium Winans et al. (1989) J. Bact. 171:1616-1622
- Agrobacterium cells were mixed at the volume ratio of 3:1 (plant cell:AgroJba ⁇ teriu_n cell) with the friable calli selected after 6 months. Calli and
- Agrobacterium were placed on 7.0 cm sterile Whatman #1 filter paper circles on the top of cocultivation medium N12 supplemented with 100 ⁇ M acetosyringone. Plates were placed in a 24°C controlled environment incubator in the dark for 48 hours.
- Calli were washed from Agrobacterium with the liquid medium N12 supplemented with 500 mg/1 carbenicillin. Calli were mixed well with the medium at a volume ratio of 1:10 (calli:medium) , centrifuged (500 rpm for 5 min.), and the supernatant was discarded. Washing was repeated 4 times.
- the callus tissue from part 2 were transferred to maturation medium M134-53 for 3-5 weeks.
- the tissue was subsequently cultured in maturation medium M20 for 9- 11 weeks.
- the callus tissue from part 7 was cultured in maturation medium M20 for either 8 or 11 weeks. On this medium, mature embryos were obtained starting after four weeks and continuing afterwards. Mature embryos appeared on structures with wide cotyledons (usually 2 and occasional 3 or 4) and very short hypocotyl and radical. The embryos were white. The same results were obtained for both the 8 week and 11 week culture period. 9. Culture on germination medium.
- Germination of the matured embryonic tissue was accomplished on M13 medium after 2 weeks. Under 16 hr/day light illumination (around 1500 lux) tissues became green, cotyledons expanded 5-10 times, and embryos enlarged in size 3-5 times and produced 1-5 green shoots. Alternatively, germination of the matured embryonic tissue was accomplished in N3-1 medium. The tissue was incubated on N3-1 medium for 3 weeks. The fully germinated embryos were then transferred to M13 medium to complete plantlet development. After 6 weeks, well developed plantlets were obtained and were in condition for transfer to artificial soil. Axillary shoot proliferation was observed. 10. Culture on shoot multiplication medium.
- Germinated embryos were subcultured on fresh M13 medium. On this medium shoots multiplied further, and after 4 weeks, ten to 30 shoots per original embryo were produced. 11. Culture on shoot elongation medium.
- Sections of the shoot clusters were cut off and transferred to M13-8 medium with 4-6 shoots per cluster. Shoots elongated to 10-15 cm in size within 3-4 weeks.
- Transformation was confirmed by several means: 1) transformed calli transferred onto M20K200C were able to continue their growth, whereas nontransformed control calli stopped growth on the medium, turned brown and eventually died (Table 2) ; 2) transformed calli, somatic embryos, and leaf sections from transformed shoots all tested positive and nontransformed controls tested negative in the GUS assays (Table 3) (transformants stained blue and nontransformed tissues did not stain blue) .
- Leaf callus assays were performed on five transgenic shoots.
- the medium contained 50 mg/1 kanamycin to verify that the tissues had been transformed. All transformants formed calli in the presence of the kanamycin, thus confirming transformation.
- Example 1 Same as Example 1 except AgroJa ⁇ teriuj ⁇ tumefaciens strain LBA4404 (Hoekema et al. (1983) , supra . ) containing the binary vector pJJ3931 (Fig. 8) was used for transformation.
- pJJ3931 is same as pJJ3499 except that it carries the luciferase (LUC) gene (Ow et al. (1986), supra. ) instead of GUS, under the control of 35S promoter, used as a reporter gene. 4.
- Cocultivation on cocultivation medium Same as Example 1. 5. Wash.
- Example 1 Same as Example 1 except that 25 out of 33 inoculated calli produced kanamycin-resistant calli (Table 1) .
- Transformation was confirmed by several means: 1) transformed calli were able to continue growth on M20 K200C medium (Table 2) and 2) most transformed calli tested positive and non-transformed calli tested negative in a LUC assay (Table 4 and Fig. 9) TABLE 4
- FIG. 1 Methods used to produce somatic embryos from leaf explants from Rosa hybrida L. var. Sonia are shown in Figure 5.
- Leaves from in vitro shoots of .Rosa hybrida L. var. Sonia (Figure 2A) were used as explant source for callus induction. Shoots from lateral buds were cultured on Hasegawa medium (Hasegawa (1979) 14:610-612). Leaf base and apical regions were removed before inoculation.
- the M139 culture induction medium was used with varying hormone concentrations: 2,4-D (1.5-2.0 mg/1), Zeatin (1.0-2.0 mg/1) and ABA (0-0.2 mg/1). Leaves cultured in this callus induction media formed a very spongy tissue after 3-4 weeks (Figure 2B) . These spongy calli were cultured in W25-1 consisting of White salts (White (1943) Handbook of Plant Tissue Culture,
- This regeneration medium consisted of modified White salts as in W25-1, thiamine-HCl (5 mg/1) , inositol (100 mg/1) , pyridoxine (1.5 mg/1), nicotinic acid (1.5 mg/1), glycine (2.0 mg/1), KIN (2.0 mg/1), NAA (0.25 mg/1), sucrose (20 g/1), and Sigma agar (6 g/1); pH 5.6. Somatic embryos at early developmental stage were visible in W26-1 after 4 weeks on regeneration medium ( Figure 3D) .
- the invention described and claimed herein is not to be limited in scope by the specific embodiments herein disclosed, since these embodiments are intended as illustrations of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP91513304A JPH05507415A (ja) | 1990-06-25 | 1991-06-21 | バラ植物及びそれらの生産方法並びに遺伝的形質転換 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US678,846 | 1984-12-06 | ||
US54284190A | 1990-06-25 | 1990-06-25 | |
US67884691A | 1991-04-01 | 1991-04-01 | |
US542,841 | 1991-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992000371A1 true WO1992000371A1 (fr) | 1992-01-09 |
Family
ID=27067163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/004412 WO1992000371A1 (fr) | 1990-06-25 | 1991-06-21 | Rosiers et leurs procedes de production et de transformation genetique |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0536327A1 (fr) |
JP (2) | JPH05507415A (fr) |
WO (1) | WO1992000371A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2040174A1 (es) * | 1992-02-24 | 1993-10-01 | Consejo Superior Investigacion | Metodo para el enraizamiento de estaquillas semilenosas de chirimoyo (anona cherimola mill.) cv. fino de jete, micropropagadas por cultivo de tejidos in vitro. |
US5646333A (en) * | 1994-09-02 | 1997-07-08 | Drexel University | Plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
US5843782A (en) * | 1995-02-09 | 1998-12-01 | Novaflora, Inc. | Micropropagation of rose plants |
WO1999038373A1 (fr) * | 1998-02-02 | 1999-08-05 | Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada | Regeneration d'embryons somatiques de tissus vegetaux |
US6339185B1 (en) | 1994-09-02 | 2002-01-15 | Drexel University | Plant termination sequence |
CN102286523A (zh) * | 2011-07-19 | 2011-12-21 | 华中农业大学 | 农杆菌介导的玫瑰遗传转化方法 |
CN102884984A (zh) * | 2012-11-05 | 2013-01-23 | 湖南农业大学 | 一种月月红体细胞胚胎发生及植株再生方法 |
US8629258B2 (en) | 2006-06-01 | 2014-01-14 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Plant nucleic acids associated with cellular pH and uses thereof |
CN108575762A (zh) * | 2018-07-18 | 2018-09-28 | 苏州枫彩生态科技集团有限公司 | 一种提高红枝木组培苗增殖率的方法 |
CN110810246A (zh) * | 2019-12-03 | 2020-02-21 | 赵健华 | 一种红芽大戟繁育方法 |
CN111887155A (zh) * | 2020-06-29 | 2020-11-06 | 南京锦江园林景观有限公司 | 一种提高蔷薇属植物高效快速成苗的方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1652916B1 (fr) | 2003-08-13 | 2011-10-05 | Suntory Holdings Limited | Procede de production d'une rose de couleur modifiee |
US8183434B2 (en) * | 2007-03-29 | 2012-05-22 | Suntory Holdings Limited | Method for producing transgenic surface layer chimeric plant |
EP2238826A4 (fr) | 2007-12-07 | 2010-12-15 | Suntory Holdings Ltd | Plante transgénique capable de fleurir dans des conditions de faible intensité lumineuse |
WO2010122848A1 (fr) | 2009-04-24 | 2010-10-28 | インターナショナル フラワー ディベロプメンツ プロプライアタリー リミティド | Promoteur issu de perilla frutescens var. crispa fonctionnant dans les pétales |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1241334A (fr) * | 1959-10-14 | 1960-09-16 | Vilmorin Andrieux | Rosier enraciné du type <<hybride de polyantha>> à fleurs en bouquets, au port érigé, produisant des fleurs roses |
FR1423068A (fr) * | 1964-11-19 | 1966-01-03 | Rosier enraciné floribunda avec des fleurs rouge cardinal et son procédé d'obtention | |
US4672035A (en) * | 1984-03-16 | 1987-06-09 | Research Corporation | Controlled regeneration of cotton plants from tissue culture |
-
1991
- 1991-06-21 EP EP91914009A patent/EP0536327A1/fr not_active Withdrawn
- 1991-06-21 JP JP91513304A patent/JPH05507415A/ja active Pending
- 1991-06-21 WO PCT/US1991/004412 patent/WO1992000371A1/fr not_active Application Discontinuation
-
2000
- 2000-11-27 JP JP2000359912A patent/JP2001190169A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1241334A (fr) * | 1959-10-14 | 1960-09-16 | Vilmorin Andrieux | Rosier enraciné du type <<hybride de polyantha>> à fleurs en bouquets, au port érigé, produisant des fleurs roses |
FR1423068A (fr) * | 1964-11-19 | 1966-01-03 | Rosier enraciné floribunda avec des fleurs rouge cardinal et son procédé d'obtention | |
US4672035A (en) * | 1984-03-16 | 1987-06-09 | Research Corporation | Controlled regeneration of cotton plants from tissue culture |
Non-Patent Citations (8)
Title |
---|
Acta Horticulture, Volume 212, issued 1987, VALLES et al., "Regeneration from Rosa callus", pages 691-696, see the entire document. * |
EVANS et al., eds., "Hand book of plant cell culture", Volume 1, published 1983 by McMillian & Son, pages 82-123, see the entire document. * |
Hortscience, Volume 19, No. 1, issued February 1984, WANG et al., "Somatic embryogenesis and plant regeneration from immature embryos of strawberry", pages 71-72, see the entire document. * |
Plant Cell Reports, Volume 9, issued 1990, DeWIT et al., "Somatic embryogenesis and regeneration of flowering plants in rose", pages 456-458, see the entire document. * |
Plant Cell, Tissue and Organ Culture, Volume 21, issued 1990, BURGER et al., "Organogenesis and plant regeneration from immature embryos of Rosa hybrida L", pages 147-152, see the entire document. * |
See also references of EP0536327A4 * |
VASIL, ed., "Cell culture and somatic cell genetics of plants", published 1986 by Academic Press, Inc., pages 245-246 and 252, see the entire document. * |
VASIL, ed., "Cell culture and somatic cell genetics of plants", Volume 3, published 1986, by Academic Press, Inc., pages 49-50. * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2040174A1 (es) * | 1992-02-24 | 1993-10-01 | Consejo Superior Investigacion | Metodo para el enraizamiento de estaquillas semilenosas de chirimoyo (anona cherimola mill.) cv. fino de jete, micropropagadas por cultivo de tejidos in vitro. |
US5646333A (en) * | 1994-09-02 | 1997-07-08 | Drexel University | Plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
US5744334A (en) * | 1994-09-02 | 1998-04-28 | Drexel University | Plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
US6339185B1 (en) | 1994-09-02 | 2002-01-15 | Drexel University | Plant termination sequence |
US5843782A (en) * | 1995-02-09 | 1998-12-01 | Novaflora, Inc. | Micropropagation of rose plants |
US5952231A (en) * | 1995-02-09 | 1999-09-14 | Novaflora, Inc. | Micropropagation of rose plants |
US6071746A (en) * | 1998-02-02 | 2000-06-06 | Agriculture And Agri-Food Canada | Regeneration of somatic embryos from plant tissues |
WO1999038373A1 (fr) * | 1998-02-02 | 1999-08-05 | Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada | Regeneration d'embryons somatiques de tissus vegetaux |
US8629258B2 (en) | 2006-06-01 | 2014-01-14 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Plant nucleic acids associated with cellular pH and uses thereof |
CN102286523A (zh) * | 2011-07-19 | 2011-12-21 | 华中农业大学 | 农杆菌介导的玫瑰遗传转化方法 |
CN102286523B (zh) * | 2011-07-19 | 2013-03-20 | 华中农业大学 | 农杆菌介导的玫瑰遗传转化方法 |
CN102884984A (zh) * | 2012-11-05 | 2013-01-23 | 湖南农业大学 | 一种月月红体细胞胚胎发生及植株再生方法 |
CN108575762A (zh) * | 2018-07-18 | 2018-09-28 | 苏州枫彩生态科技集团有限公司 | 一种提高红枝木组培苗增殖率的方法 |
CN110810246A (zh) * | 2019-12-03 | 2020-02-21 | 赵健华 | 一种红芽大戟繁育方法 |
CN111887155A (zh) * | 2020-06-29 | 2020-11-06 | 南京锦江园林景观有限公司 | 一种提高蔷薇属植物高效快速成苗的方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0536327A4 (fr) | 1994-02-16 |
JPH05507415A (ja) | 1993-10-28 |
EP0536327A1 (fr) | 1993-04-14 |
JP2001190169A (ja) | 2001-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5792927A (en) | Genetically transformed rose plants and methods for their production | |
EP0910239B1 (fr) | Transformation des cotonniers | |
US5286635A (en) | Genetically transformed pea plants and methods for their production | |
US20090151023A1 (en) | Transformation system for Camelina sativa | |
WO1992000371A1 (fr) | Rosiers et leurs procedes de production et de transformation genetique | |
Mori et al. | Callus formation and plant regeneration in various Lilium species and cultivars | |
US5567599A (en) | Method for producing transformed chrysanthemum plants | |
JP2020005538A (ja) | Taraxacum属植物の形質転換植物の製造方法 | |
US5589613A (en) | Carnation plants and methods for their transformation and propagation | |
US20030093829A1 (en) | Doubled haploid production and genetic transformation | |
AU706650B2 (en) | Genetic modification of plants | |
US6197587B1 (en) | Methods and tissue culture media for inducing somatic embryogenesis, agrobacterium-medicated transformation and efficient regeneration of cacao plants | |
AU744496B2 (en) | Method of genetically transforming banana plants | |
US7897838B2 (en) | Methods for high efficiency transformation and regeneration of plant suspension cultures | |
US20010007157A1 (en) | Genetically transformed rose plants and methods for their production | |
WO1997043430A1 (fr) | Procede de regeneration in vitro rapide de plants de coton compatible avec une transformation effectuee par l'intermediaire de l'agrobacterie | |
US20030046733A1 (en) | Transformation of soybeans | |
US20040210959A1 (en) | A Novel Method for Production of Transformed Dihaploid Corn Plants | |
US20040210958A1 (en) | A Novel Culture Method for Corn Transformation | |
US20020199220A1 (en) | Methods to propagate plants via somatic embryogenesis and to transfer genes into ornamental statice and other members of the family plumbaginaceae | |
AU715536B2 (en) | Method of regeneration of medicago sativa and expressing foreign DNA in same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/9-9/9,DRAWINGS,REPLACED BY NEW PAGES 1/13-13/13;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991914009 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1991914009 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1991914009 Country of ref document: EP |